The CDK1-Related lncRNA and CXCL8 Mediated Immune Resistance in Lung Adenocarcinoma

Background: Limited therapeutic options are available for advanced LUAD without driver gene mutations. Anti-CDK therapy has shown effectiveness in several kind of cancers, however, the mechanisms still need to be elucidated. Materials and Methods: The lncRNA associated with CDK1 and the immunomodula...

Descripción completa

Detalles Bibliográficos
Autores principales: Xue, Jinmin, Song, Yang, Xu, Wenwen, Zhu, Yuxi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9454767/
https://www.ncbi.nlm.nih.gov/pubmed/36078096
http://dx.doi.org/10.3390/cells11172688

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9454767/
https://www.ncbi.nlm.nih.gov/pubmed/36078096
http://dx.doi.org/10.3390/cells11172688

Ejemplares similares